ANANYA SREEPATHI: Open Payments
NPI 1265813471 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 70 payments from 12 companies in 2025. Trend: 2023 $91 · 2024 $904 · 2025 $1,834
Food & beverage: $1,723Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $312 |
| Corium, LLC | 12 | $299 |
| Teva Pharmaceuticals USA, Inc. | 5 | $226 |
| ABBVIE INC. | 8 | $202 |
| Lundbeck LLC | 6 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $159 |
| Collegium Pharmaceutical, Inc. | 7 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| Supernus Pharmaceuticals, Inc. | 4 | $104 |
| Axsome Therapeutics, Inc. | 2 | $58 |
Products named: REXULTI, Azstarys, VRAYLAR, CAPLYTA, Jornay PM, TRINTELLIX, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
